Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This is a novel, uncharacterized long non-coding RNA transcribed antisense to the COX6A2 gene, also known as cytochrome c oxidase subunit 6A2. COX6A2 is a nuclear-encoded subunit of cytochrome c oxidase (complex IV) in the mitochondrial electron transport chain, primarily expressed in muscle and certain interneurons[2][3][4][1]. The antisense transcript may play a regulatory role in the expression of COX6A2, but there is no experimental data confirming its function, clinical relevance, or druggability. This transcript is not a therapeutic target, enzyme, receptor, transporter, or transcription factor based on current evidence.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on novel transcript, antisense to cytochrome c oxidase subunit 6A2.